The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Co-Danthramer 25mg/200mg per 5ml Oral Suspension

Pinewood Laboratories LtdPA0281/080/001

Main Information

Trade NameCo-Danthramer 25mg/200mg per 5ml Oral Suspension
Active SubstancesDantron
Poloxamer 188
Dosage FormOral suspension
Licence HolderPinewood Laboratories Ltd
Licence NumberPA0281/080/001

Group Information

ATC CodeA06AB Contact laxatives
A06AB53 dantron, combinations


License statusWithdrawn
Withdrawn Date20/12/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back